This product is a recombinant humanized antibody that specifically binds to human transferrin receptor (TfR) and primate TfR. The antibody was purified by affinity chromatography.
Figure 1 Anti-Human TfR Antibody (TAB-611CT) in ELISA
ELISA analysis of TAB-611CT was performed by coating with Cynomolgus Transferrin Receptor Protein and Human Transferrin Receptor Protein.
Red line: Recombinant Cynomolgus Transferrin Receptor Protein (His Tag)
Blue line: Recombinant Human Transferrin Receptor Protein (His Tag)
Figure 2 Anti-Human TfR Antibody (TAB-611CT) in WB
Western blot analysis of TAB-611CT was performed with Recombinant Human Transferrin Receptor Protein.
Lane 1: Blank
Lane 2: Blank
Lane 3: 40ng Recombinant Cynomolgus Transferrin Receptor Protein
Lane 4: 40ng Recombinant Cynomolgus Transferrin Receptor Protein
Lane 5: Marker
Lane 6: 40ng Recombinant Human Transferrin Receptor Protein
Lane 7: 80ng Recombinant Human Transferrin Receptor Protein
Lane 8: 160ng Recombinant Human Transferrin Receptor Protein
Lane 9: 320ng Recombinant Human Transferrin Receptor Protein
Lane 10: Blank
Desjardins, Cody A., et al. "Enhanced exon skipping and prolonged dystrophin restoration achieved by TfR1-targeted delivery of antisense oligonucleotide using FORCE conjugation in mdx mice." Nucleic acids research 50.20 (2022): 11401-11414.
This study focuses on developing an enhanced delivery mechanism for phosphorodiamidate morpholino oligomers (PMO) to treat Duchenne muscular dystrophy (DMD). Traditional therapies aim to induce exon skipping in the dystrophin pre-mRNA to produce a functional dystrophin protein. However, these therapies often face challenges in effectively delivering PMO to cardiac and skeletal muscles. To address this, the researchers developed the FORCE™ platform, which utilizes a Fab fragment targeting the transferrin receptor 1 (TfR1) conjugated to the PMO. This approach demonstrated significantly improved muscle delivery, achieving dose-dependent and robust exon skipping and sustained dystrophin restoration in mdx mice, a model for DMD.
Creative Biolabs provided several key products for this study, significantly contributing to its success. They supplied the human monoclonal antibody targeting human TfR1 (15G11, Cat# TAB-611CT), which was essential for validating the specificity and efficacy of the FORCE™ conjugate. Additionally, Creative Biolabs provided other critical reagents and antibodies that facilitated the extensive biochemical and molecular analyses conducted in the study. These contributions were crucial in enabling the detailed examination of the FORCE™ platform's ability to enhance PMO delivery and restore dystrophin expression, thereby demonstrating its potential as an effective treatment approach for DMD.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
AGTO-G067E | Anti-TFRC immunotoxin HB21 (scFv)-PE | Cytotoxicity assay, Function study | |
AGTO-G067D | Anti-TFRC immunotoxin HB21 (scFv)-DT | Cytotoxicity assay, Function study | |
AGTO-G067G | Anti-TFRC immunotoxin HB21 (scFv)-Gel | Cytotoxicity assay, Function study | |
AGTO-G067R | Anti-TFRC immunotoxin HB21 (scFv)-RTA | Cytotoxicity assay, Function study | |
AGTO-G067S | Anti-TFRC immunotoxin HB21 (scFv)-Sap | Cytotoxicity assay, Function study |
To accurately reference this product in your publication, please use the following citation information:
(Creative Biolabs Cat# TAB-611CT, RRID: AB_3111977)
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.